Dual farnesoid X receptor/TGR5 agonist INT‐767 reduces liver injury in the Mdr2−/− (Abcb4−/−) mouse cholangiopathy model by promoting biliary HCO 3− output

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|54|4|1303-1312

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.54, Iss.4, 2011-10, pp. : 1303-1312

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Farnesoid X receptor–induced lysine‐specific histone demethylase reduces hepatic bile acid levels and protects the liver against bile acid toxicity

By  

HEPATOLOGY, Vol. 62, Iss. 1, 2015-07 ,pp. : 220-231

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intestinal farnesoid X receptor puts a fresh coat of wax on fatty liver

By  

HEPATOLOGY, Vol. 62, Iss. 2, 2015-08 ,pp. : 646-648

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cardiomyopathy reverses with recovery of liver injury, cholestasis and cholanemia in mouse model of biliary fibrosis

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 4, 2015-04 ,pp. : 1464-1477

John Wiley & Sons Inc

Access to resources Recommend Favorite

Selective endothelin A receptor antagonism with sitaxentan reduces neointimal lesion size in a mouse model of intraluminal injury

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 11, 2015-06 ,pp. : 2827-2837

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of combination antiretroviral therapy in the NOD.c3c4 mouse model of autoimmune biliary disease

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 4, 2015-04 ,pp. : 1442-1450

John Wiley & Sons Inc

Access to resources Recommend Favorite